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W1 ABSTRACT 
A portion of an organic polymer article such as a mem- 
brane is made hydrophilic by exposing a hydrophobic 
‘surface of the article to a depth of about 50 to about 
5000 angstroms to atomic oxygen or hydroxyl radicals 
at a temperature below 100” C., preferably below 40” 
C., to form a hydrophilic uniform surface layer of hy- 
drophilic hydroxyl groups. The atomic oxygen and 
hydroxyl radicals are generated by a flowing afterglow 
microwave discharge, and the surface is outside of a 
plasma produced by the discharge. A membrane having 
both hydrophilic and hydrophobic surfaces can be used 
in an immunoassay by adhering antibodies to the hydro- 
phobic surface. In another embodiment, the membrane 
is used in cell culturing where cells adhere to the hydro- 
philic surface. Prior to adhering cells, the hydrophilic 
surface may be grafted with a compatibilizing com- 
pound. A plurality of hydrophilic regions bounded by 
adjacent hydrophobic regions can be produced such 
that a maximum of one cell per each hydrophilic region 
adheres. 
10 Claims, 1 Drawing Sheet 
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Polymer prostheses have been considered for vascu- 
lar applications. C. Stimpson et al., in Biomaterials, Arti- 
ficial Cells, and Artificial Organs, 17( l), (1989), pp. 3 1-43 
discloses silicone rubber canine aortic prostheses. A 
5 uniformly microporous prosthesis is made by molding 
the polymer in a template taken from the skeletal struc- 
ture of a marine life form. 
Durrani et al., in Polymer Surfaces and Interfaces, 
chapter 10, J Wiley & Sons, (1987), pages 189-200 dis- 
10 closes modification of polymer surfaces with a phos- 
surfaces in bioapplications. Modifications of this sort are 
ciated with the use of blood contacting devices. 
METHOD OF MAKING A MEMBRANE HAVING 
HYDROPHILIC AND HYDROPHOBIC SURFACES 
FOR ADHERING CELLS OR ANTIBODIES BY 
USING ATOMIC OXYGEN OR HYDROXYL 
RADICALS 
ORIGIN OF THE INVENTION 
The invention described herein was made by em- 
United States of America for governmental purposes 
for. 
ployee(’) Of the United States Government Of the phorylcholine, for example, to biomembrane 
without the payment Of royalties thereon or there- to reduce foreign surface induced thromboses asso- 
FIELD OF THE INVENTION 
The present invention relates to a method for making 
biocompatible polymer articles using a uniform atomic 
oxygen treatment, and more particularly to polymer 
articles having a biocompatibilized surface comprising 
grafts of uniformly distributed compatibilizing com- 
pounds and a method for making such articles. The 
invention also relates to vascular prostheses having a 
biocompatibilized surface comprising a uniform distri- 
bution of living cells adhered thereto. The invention 
further relates to atomic oxygen modified membranes 
useful in medical diagnostic procedures and biochemi- 
cal manufacture. 
BACKGROUND OF THE INVENTION 
The use of polymeric materials for biomedical im- 
plants and in biotechnical manufacture is an advancing 
art. Plasma discharges have been used to engineer such 
polymers because surface chemistry can be altered 
without adversely affecting bulk properties which make 
polymeric materials useful. However, plasma devices 
typically do not deliver a uniform concentration of the 
reactive species. Subject to complex interactions, non- 
uniform distribution of plasma species may increase 
manufacturing difficulty and impair quality control. 
Silicone rubber has long been used in medical devices 
such as surgical implants due to desirable properties 
including gas permeability, pliability, degradation resis- 
tance, ease of fabrication and relatively good biocom- 
patibility. However, such materials are not completely 
inert in the body. Recent methods have been sought to 
improve its biologic inertness by either surface modifi- 
cation to increase hydrophilicity or bulk modification, 
i.e. incorporating polar groups into the monomer or 
prepolymer. Tsai, Chi-Chun et al., in Transactions of the 
American Society of Artificial Internal Organs (ASAIO), 
vol. XXXIV, (1988) discloses a method for increasing 
the albumin affiity of silicone rubber. A vinyl-methyl 
silicone comonomer was hydroxylated and then film 
coated on a silicone rubber sheet. The OH-coated sheet 
was grafted with a c16 alkyl chain having a terminal 
acyl group by an esterification reaction catalyzed by 
4dimethylaminopyridine. Albumin adsorption and re- 
tention was said to be markedly enhanced for surface 
OH and C16 concentrations as low as 5% reaction yield. 
Tsai, Chi-Chun et al., in ASAIO, vol. XXXVI, (1990) 
discloses use of the above albumin adsorbed silicone 
surfaces as thin transparent, biocompatible films for 
coating the surfaces of blood contacting devices. These 
films are said to retard undesired responses, e.g. blood 
coagulation and activation of complement proteins, 
15 
20 
25 
Rajender Sipehia in Biomaterials, Artificial Cells, and 
Artificial Organs, 16(5), (1988-89), pp. 955-966 discloses 
immobilizing proteins to polymeric surfaces. Polypro- 
pylene membranes are treated by gaseous oxygen or 
ammonia plasma to add hydroxyl or amino groups to 
the polymer surface. The proteins are then grafted to 
the surface. Rajender Sipehia in Biomaterials, Artificial 
Cells, and Artificial Organs, 18(3), (1990), pp. 437-446 
discloses ammonia plasma modification of polystyrene 
petri dishes and poly(tetrafluoroethy1ene) membranes 
and grafting of proteins to the surface. The growth of 
bovine Dulmonarv arterv endothelial cells on the modi- 
fied &ace is erhanceh by adherence to the grafted 
proteins. 
In U.S. Pat. No. 4,134,949 to Chen, the surface of a 
30 contact lens is modified by deposition of a hydrophilic 
polymer under the influence of plasma glow discharge 
to integrally bond the coating to the surface of a hydro- 
phobic lens. 
Elizabeth G. Nabel et al., in Science, vol. 244, 16 Jun. 
35 1989, pp. 1342-1345 discloses a transplant of endothelial 
cells expressing a recombinant gene into an arterial 
wall. The transplanted cells may contribute to altering 
the thrombic properties of the vessel lumen by inducing 
smooth muscle cell proliferation and regulating smooth 
40 muscle cell tone. In addition, genetically altered cells 
could transmit recombinant DNA products. 
Polymer surfaces have been modified by plasma ap- 
plication to prepare membranes for dialysis and ultrafil- 
tration. Hiroo Iwata et al. in Journal of Membrane Sci- 
45 ence, vol. 38, (1988), pp. 185-189 discloses a porous 
poly(viny1idene fluoride) membrane pretreated by air 
plasma and subsequent graft polymerization of hydro- 
philic monomers on the treated surface. Such mem- 
branes are said to be environment-sensitive and can be 
50 used to mimic biological membranes or in a closed-loop 
drug delivery system. J. Wolff, Journal of Membrane 
Science, vol. 36, (1988), pp. 207-214; F. Vigo et al., 
Journal of Membrane Science, vol. 36, (1988), pp. 
187-199; F. F. Stengaard, Journal of Membrane Science, 
55 vol. 36, (1988) , pp. 257-275; and Fang Yuee et al., 
Journal of Membrane Science, vol. 39, (1988), pp. 1-9 
disclose the preparation of a variety of dialyses and 
ultrafiltration membranes. 
Various polymers have been modified by plasma 
60 processes to alter surface chemistry, adhesion proper- 
ties, and the like. See H. K. Yasuda et al., Polymer Sur- 
faces and Interfaces, chapter 8, J Wiley & Sons, (1987), 
pages 149-162. 
SUMMARY OF THE INVENTION 65 
The method of the Dresent invention is based on the 
platelets and white blood cells, triggered by exposure of 
blood stream macromolecules to a foreign surface. 
discovery of an atomii oxygen treatment method capa- 
ble of producing a substantially uniform concentration 
5,369,012 
3 4 
of reactive atomic oxygen species. Polymer substrates 
so treated have a uniform distribution of hydrophilic 
functionality on the treated surface. Such functionality 
is useful for biocompatibilizing polymer articles for 
biomedical and biotechnical applications. 5 membrane cells is obtained. 
gions at a maximum density of one cell per each hydro- 
philic region and hydrophobic regions are substantially 
free of adhered cells. The cells are grown on the mem- 
brane and a count of malignant cells growing on the 
In one embodiment, the present invention provides a 
biotechnical method, comprising the steps of: (a) expos- 
ing a hydrophobic exterior polymer surface to a sub- 
stantially axially uniform dosage of atomic oxygen or 
hydroxyl radicals at a temperature below about 100" C. 
sufficient to form a uniform layer of hydrophilic hy- 
droxyl radically on said surface, wherein the dosage is 
generated by a flowing afterglow microwave discharge, 
wherein the surface is outside of a plasma produced by 
the discharge; and (b) recovering a biocompatible arti- 
cle. The method may further comprise the steps of 
grafting a compatibilizing compound to the surface 
following the exposing step and adhering a layer of 
living cells to the compatibilizing compound. The graft- 
As yet another preferred aspect, the method of the 
invention can be used to culture cells with enhanced 
recovery of biological products. A membrane with first 
and second opposing surfaces is prepared wherein the 
0 first surface comprises a hydrophilic area bounded by a 
hydrophobic area as described above. Cell culturing 
and product compartments are formed separated by the 
membrane, wherein the first membrane surface is adja- 
cent the cell culturing compartment and the second 
5 membrane surface is adjacent the product compart- 
ment, the cell culturing compartment comprising cells 
in a growth medium, the cells having a gene for the 
expression of a desired product. The cells are induced to 
adhere to the hydrophilic area of the first surface of the 
ing step may include t i e  preh&ary step of treating the 20 membrane, wherein the cells polarize with a basal cell 
surface with a dihalodialkylsilane coupling agent. The wall adjacent the first surface. Nutrient migration is 
compatibilizing compound is preferably selected from induced from the nutrient compartment to the cells 
the group consisting of bioactive compounds such as compartment by maintaining nutrient in the cell cultur- 
phosphorylcholines, peptide sequences, lipids and pro- ing compartment, wherein the cells absorb the nutrient 
teins; polymers such a poly(ethy1ene oxide) and poly(vi- 25 and in response thereto secrete a product preferentially 
nyl alcohol); and compounds comprising acyl termi- through the basal cell wall and the membrane into the 
nated upper alkyl radicals. The dosage over the exposed product compartment. 
surface preferably comprises a concentration within As yet a further preferred aspect, the method of the 
about 10 percent of an average dosage over the surface invention can be used to culture cells with self-replen- 
and is essentially free of atomic oxygen dose variation in 30 ishing nutrients. A membrane is prepared with a first 
a radial direction. As one preferred aspect, the method hydrophobic surface and a second hydrophilic surface 
of the invention can be used to vascularize a cell mass as described above. A nutrient compartment and a cells 
wherein a prosthesis is prepared from a polymeric tube compartment are formed on opposite sides of the mem- 
having an outside surface biocompatibilized with an brane, wherein the second surface is adjacent the nutri- 
adhered layer of cells as described above and then in- 35 ent compartment and the first surface is adjacent the 
serting the prosthesis into the cell mass. In general, an cells compartment, the nutrient compartment compris- 
implantable article can be prepared by appropriately ing a solution of nutrient and the cells compartment 
treating membranes, tubes or molded forms. comprising cells in a growth medium. Migration is in- 
As another preferred aspect, the method of the inven- duced of said nutrient from said nutrient compartment 
tion can be used to conduct an enzyme-linked im- 40 to said cells compartment by maintaining a concentra- 
munosorbent assay test. A membrane having a hydro- tion of said nutrient in said nutrient compartment. 
philic surface and a hydrophobic surface is prepared as In another embodiment, the invention provides bi- 
described above. Known antibodies are adhered to the otechnical polymer articles suitable for use in biomedi- 
hydrophobic surface. Then the hydrophilic surface is cal or biotechnical applications, comprising at least one 
placed in contact with an adjacent absorbent material. 45 surface biocompatibilized at least in part by the method 
The antibodies are covered with a test solution, wherein described above. The biocompatibilized surface can 
antigens specific to the antibodies adhere thereto to comprise a substantially uniform distribution of reactive 
form an antibody-antigen complex and the non-compat- hydrophilic functionality, a compatibilizing compound 
ible antigens are absorbed by the absorbent material. grafted to the surface using the hydrophilic functional- 
The hydrophobic surface is covered with a solution of 50 ity and/or a layer of living cells adhered to the surface 
the antibodies conjugated to an indicating enzyme, using the hydrophilic functionality and/or the com- 
wherein the conjugated antibodies and the antigen-anti- patibilizing compounds. Examples of such articles in- 
body complex form an antibody-antigen-antibody/en- clude vascular prostheses, membranes, dressing textiles, 
zyme complex and excess fluid is absorbed by the absor- molded implants having surfaces inhibiting platelet ad- 
bent material. The antibody-antigen-antibody/enzyme 55 hesion and articles having surfaces enhancing cell adhe- 
complex are developed with a solution of developing sion. 
compound reactive with the enzyme to indicate pres- In a further embodiment, the invention provides a 
ence of the antibody-antigen-antibody/enzyme com- bioreactor comprising a housing; a membrane having at 
plex as a positive result or an absence of the complexes least a portion of one biocompatibilized surface made by 
as a negative result, wherein excess developing solution 60 the method described above dividing the housing into 
is absorbed by the absorbent material. an opposing nutrient compartment and product com- 
As a further preferred aspect, the method of the in- partment; and cells in a growth medium in the nutrient 
vention can be used to culture cells for malimant cell compartment. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic cross-sectional representation 
of a sidearm afterglow atomic oxygen reactor suitable 
for use in the present invention. 
evaluation. A membrane is prepared havinga surface 
comprising a plurality of hydrophilic regions bounded 65 
by hydrophobic regions as described above. A group of 
cells are distributed on the membrane in a growth me- 
dium, wherein the cells adhere to the hydrophilic re- 
5,369,012 
5 6 
FIG. 2 is a schematic cross-sectional view of the endothelial cells adhered to the protein grafts. Further- 
sidearm atomic oxygen reactor of FIG. 1 as seen along more such cells can be genetically altered to transmit 
the lines 2-2. recombinant DNA products. Such substrates can be 
utilized in vascular, skeletal, and the like prostheses; as 
5 a vascular network for microgravity cell culturing pro- DETAILED DESCRIPTION OF THE 
cesses; or in earth-based bioprocessing methodology, INVENTION 
A substantially uniformly compatiblized polymer e.g. affinity columns. Vascular prostheses can be used in 
article for a biologic environment, Le. in the presence of persons suffering advanced arteriosclerosis. 
bioactive molecules, can be obtained by treating a suffi- To limit oxidation the outer portion of the substrate 
cient amount of surface of the article with a substan- 10 and avoid altering the bulk properties of the polymer, 
tially uniform concentration of an oxidizing plasma highly reactive atomic oxygen or hydroxyl radicals are 
species, then optionally grafting compatibilizing com- preferred oxidizing agents. Atomic oxygen has the ad- 
pounds to the treated surface. In addition, the grafted vantage over molecular oxygen of obtaining a distinct 
substrate may be used as a base for succeeding grafts or oxidation front, generally on the order of a molecular 
as an adhesive layer for proteins or living cells. 15 diameter, i.e. from about 50 to about 5000 angstroms. In 
In one aspect, a hydrophobic polymer substrate may addition, atomic oxygen does not require the high tem- 
be treated with a substantially uniform concentration of peratures that thermal, molecular oxygen requires, so 
atomic oxygen or hydroxyl radicals to form a substan- there are no thermally induced changes in the physical 
tially uniform hydrophilic surface layer on the sub- or structural characteristics of the polymer when the 
strate. The hydrophilic surface substantially comprises 20 atomic oxygen is used at a low temperature, preferably 
reactive hydroxyl functionality. A hydrophilic surface below about loo” C., and more preferably below about 
may be used to enhance water wettability of the sub- 40” C. 
strate, enhance surface adsorption of proteins or other To obtain uniform treatment of the substrate, a flow- 
bioactive compounds, enhance surface adherence of ing afterglow discharge type atomic oxygen reactor is 
cells or as a base for further surface compatibilizing 25 generally required. The surface of the article to be 
grafting reactions. treated should be out of the plasma and the reactor 
As another aspect, the substantially hydrophobic configured to deliver a relatively uniform dose of oxy- 
surface layer may made to undergo one or more modifi- gen atoms. The specific design of the flowing afterglow 
cations in a series of chemical reactions to graft a com- device will depend, of course, on the shape of the poly- 
patibilizing compound to the substrate surface. Various 30 mer article using the well known principles of diffu- 
kinds of compatibilizing compounds are contemplated sionheaction kinetics in flowing systems. 
and may be used so long as the result is a substrate more As a specific example, a side-arm reactor designed to 
compatible with the biologic environment of the appli- provide a uniform dose of oxygen atoms to several disk 
cation involved. By “compatibilizing,” it is meant that shaped polymer samples is described. A suitable reactor 
an otherwise non-biologic surface, e.g. hydrophobic 35 10 preferably having a sidearm 12 is best seen in FIG. 1. 
polymer surface, is made more like known biologic Reactor 10 is particularly useful for uniformly treating 
surfaces to a substantial but varying degree. The com- substrates having relatively large flat surfaces where it 
patibilizing compound may be bioactive, i.e. found in is also necessary to obtain a uniform depth of reaction 
life processes or non-bioactive but serve to compatibil- with atomic oxygen across the surface. The sidearm 
ize the substrate in situ. Representative examples of 40 atomic oxygen reactor 10 has a longitudinally oriented 
bioactive compounds which may be used include com- flow chamber 12 which may be appropriately con- 
pounds having phosphoryl-choline functionality, pep- structed of glass or another suitable material in sections, 
tide sequences, proteins, lipids, nucleic acids, and the e.g. inlet section 14, mid section 16 and discharge sec- 
like. Substrates with protein or other bioactive grafts tion 18, which are conveniently secured together using 
have several compatibilizing applications. One impor- 45 conventional coupling flanges 20,22,24 and 26. A gas 
tant use is preventing thrombosis around an implanted flow source 28 supplies gas through inlet line 30 into the 
article by mimicking biologic surfaces. As another use, inlet section 14 of the chamber 12. A discharge generat- 
grafted proteins may serve as an adherent or adsorbent ing apparatus 32 is positioned in the line 30 to generate 
for cultured cells. a discharge in the gas flowing therethrough. A micro- 
Other compounds which have been found to have a 50 wave power supply operation at 2450 Mhz, such as that 
compatibiliziing use include polymeric groups such as obtained under the trade designation Ratheon PGM-10, 
poly(viny1 alcohol) and poly(ethy1ene oxide); and an used with an Evanson-type discharge cavity, has been 
acyl terminated upper alkyl radical such as an acyl found to be suitable for this purpose. The gas entering 
terminated alkyl radical of about 16 carbon atoms. The the chamber 12 in the inlet section 14 flows axially 
former have been found to inhibit platelet sticking in the 55 therethrough and is discharged from the discharge end 
blood stream, see Y. Ikada, “Development of a Polymer 18 via line 36 in fluid communication with a vacuum 
Surface with anti-adherent Platelet Properties” com- pump 34. A plurality of sidearms 38 are positioned on 
piled in Polymers in Medicine and Surgely, Plastics and the mid section 16 transversely to the longitudinal axis 
Rubber Institute Science and Technology Publishers, thereof (see FIG. 2). The sidearms 38 are preferably 
Hornchurch, UK, 1986 which is hereby incorporated 60 radially symmetrical and six sidearms 38 are illustrated 
herein by reference. The latter has been found to have here for the purposes of example, but any number more 
enhanced affinity for blood proteins such as albumin. or less than six may be suitably used. A specimen holder 
This albumin layer inhibits clotting at the compatibil- 40 is positioned at a distal end of each sidearm conduit 
ized surface. See Tsai, Chi-Chun et al., ASAIO, vols. 42. The specimen holder 40 may be made, for example, 
XXXIV (1988) and XXXVI (1990) which are hereby 65 by modifying a conventional union fitting such as a 
incorporated herein by reference. CAJON brand union, drilled through to remove inter- 
As a further aspect, a substrate comprising a protein nal lips and to include the O-ring vacuum seals 44,46 at 
grafted polymer surface can have living cells such as either end of a sleeve member 48 adjacent the conduit 
7 
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42, so that disc-shaped specimen 49 can be held therein. 
If desired, each specimen holder may also include speci- 
men heater .well 50 and thermocouple well 52. Alter- 
nately, the specimen holder 40 may be provided with an 
adjusting mechanism to vary the distance of the speci- 5 
men from the sidearm entrance, for examde, using an 
pseudo first order reaction processes for cylindrical 
geometry reactors: 
l a  a2 
a 9  kcC(r,z) = DT - rC(r,z) + - C(r,z) 
wherein kis the rate constant for atomic oxygen loss in insert (not shown) slideably engaged in the conduc42. It is understood that while a specimen holder suited for 
a small disc-shaped article is shown, the holder design 
will depend upon shape and size of the article to be 
treated. The chamber 12 may further optionally include 
conventional sampling and probing means and appara- 
tus, such as, for example, an NO2 supply and metering 
valve connected at 54 onto inlet section 14 of the cham- 
ber 12, a capacitance manometer connection 56 on the 
discharge section 18, catalytic atomic oxygen probe 58 
positioned adjacent the sidearm 38, and the like. 
The sidearms 38 are constructed and operated so that 
no significant radial concentration gradients exist and a 
uniform atomic oxygen dose is thereby delivered to the 
substrate surface 49 which is held or secured trans- 
versely in the specimen holder 40. 
The elimination of radial concentration gradients in 
the sidearms 38 is determined by the relative magnitude 
of two characteristic relaxation times, Tdiff and T, 
wherein Tdiffis the characteristic diffusional relaxation 
time for the sidearm 38 and Trcm is the time required for 
all atomic oxygen in the sidearm to recombine. When 
Tdiffis much less than Trcm, then no significant radial 
concentration gradients exist and a uniform atomic oxy- 
gen dose is delivered to the substrate surface. Tdiffis 
determined according to the equation: 
T d y j  R2/D 
Wherein R is the diameter of the side arm conduit and 
D is the atomic oxygen diffusional coefficient (about 
120 cm% in air at 65 Pa). Trcm is determined according 
to the equation: 
TIcm = R/rcv 
wherein rcis the fraction of oxygen atoms which recom- 
bine upon striking the sidearm surface (about 3.2 x 10-4 
the sidearm conduit from all first order processes, C is 
10 the atomic oxygen concentration, r is the radial position 
from the longitudinal axis of the sidearm conduit, and z 
is an axial position (distance from the sidearm conduit 
entrance from the main gas chamber), with the bound- 
ary conditions: 
15 
C(r,z) = Cc, at z = 0; 
and 
-D c(F.2) = ksc(r,z), at z = zl ; 
20 
az 
(the specimen surface) 
wherein ksis the rate constant for atomic oxygen loss at 
25 the specimen surface. If Tdiff< <T, the partial differ- 
ential equation simplifies to: 
kcC(z) a2 
a9 7 = + - C(Z). 
30 
The complete analytical solution for the case of no 
radial dependence and first order atomic oxygen loss 
processes is as follows: 
35 
co 
C(z) = (GA + GB) C I G B ~ ~ P ~ - ( ~ C / ~ ) ~ ~ ~ Z I  + G exp[(k~/D)~% 
wherein constants GA and GB based on the above 
40 boundary conditions are: 
GA = [ o ( k ~ / D ) ~ . ~  -ks]exp[ -(kc/D)0.5zl]; and 
GB= [-o(kc/D)0.5 + ks]erp[(kc/D)o.5zl] 
45 
in thecase of glass) and V is the mean & m a l  speed of The atomic oxygen dose rate can thus be estimated, and 
oxygen atoms (about 6.3 X 104 at 300" K.1- Thus, it is readily appreciated that the dose rate can be in- 
when R= 1 cm and the reactor is operated at 65 Pa and creased dramatically by increasing the atomic oxygen 
300' K - y  Tdiffis about o-oo8 seconds and Trcm is about concentration at the sidearm conduit entrance (at z=O), 
O.' seconds. the reactor can be used to 50 and altered by the material of the sidearm conduit and 
provide a predetermined, uniform dose rate of atomic substrate. 
oxygen across the substrate surface, avoiding complica- Total atomic oxygen dose of about 1024-1026 tions resulting from the effects of boundary-layer mass cm-2day-l or may be typically obtained. The transfer which are substantially absent in the present affected substrate preferably receives an atomic oxygen device. 
55 dosage within about 10 percent of the average dosage. As an example, an atomic oxygen concentration in 
of about 1 X 1016 atoms/cm3, or about 5 percent of the be used to graft the COmpatibdking compound to the 
flowing gas at 65 pa, can be produced conven- substrate surface. Such silane grafting reactions are 
tional atomic oxygen production. Higher atomic oxy- 60 k m ~ n .  Generally, the CoUplhg agent comprises a suit- 
gen concentration in the gas chamber would obtain able functional group which may be grafted to the sub- 
higher dose rates, and lower pressure, e.g. 13 Pa of Strate surface. The grafted functional group may be 
lower would tend to also increase atomic oxygen dose made to undergo subsequent chemical reaction with an 
rate, as well as the diffusion constant (which would appropriate compatibiliing compound. Alternatively, 
increase the value of Td&. 65 the silane couping agent is attached to the compatibiliz- 
The atomic oxygen dose rate can be estimated by ing compound first. 
analytical solution of the partial differential equation One class of suitable silane coupling agents has the 
describing the diffusional transport and first order or formula: 
the gas chamber at the entrance to the side conduit As an intermediate step, a silane agent may 
9 
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fers to vivo process application, i.e. extended contact 
The extent of compatibilization depends on the given 
application. Close compatibilization may duplicate the 
5 cell linings at the location of transplant. Lesser com- 
patibilization may only require water wettability of a 
wherein R independently comprises lower alkyl radi- hydrophilic surface. Intermediate compatibilization 
cals or hydrogen, R comprises R'-Y wherein R '  corn- may mimic a biologic substrate to a greater or lesser 
Prises lower alkyl radicals and y is selected from the extent, enhance adsorption of biologic compounds such 
group Consisting of terminal amino, mercaPt0, hydroxy, 10 as albumin previously mentioned or prevent adhesion 
&OXY, glYcid0 and CarbOxY functionality. RePresenta- such as that of platelets to reduce unwanted clotting 
tive examples include 3-aminoProPYltris-(methoxy)si- also previously mentioned. It is understood that a com- 
lane, 3-mercaptopropyltris(meth0x~~~ilane, 3-gWdo- patibilked substrate for an in vivo application is less 
propyltris(methoxy)silane, 2-carboxyeth~ltris(ethox~)- likely to cause localize damage and/or irritation in an silane, 4-hydroxybutyltris(propyloxY)silane, and the 15 organism. An implant having compatibilized surfaces 
like. Another type silane Coupling agent comprises can 1 s t  longer and is generally less likely to be rejected 
vitro process will enhance the application and/or yield lane. 
In addition, a first coupling agent grafted to the sub- of the biotechnical process. 
strate or reacted with the compatibilizing compound 20 Representative examples of biomedical applications 
ing of skin, membranes for blood dialysis, prostheses for more additional coupling agents. Exemplary of such 
the vascular and skeletal system, artificial organs, im- additional coupling compounds is tresyl chloride: 
OR with ongoing life processes. 
I 
R-Si-.OR' 
I 
OR 
dihalodialkylsilanes. Exemplary iS dichlorodimethylsi- by the organism. A compatibil~ed substrate for an in 
may form an intermediate for a leaction with One Or include contact lenses, dressings for enhancing the heal- 
plants for reconstructive and cosmetic surgery, im- 
25 plants for fighting disease, implants for regulating bio- 
logical systems, implants for providing structural sup- 
port for directing vascularization wherein the support 
frame implant is later removed, and the like. 
Tresyl &loride reacts with a tennind Examples of biotechnical applications include gas and 
glycine unit of a peptide sequence to couple the se- liquid separation membranes in the manufacture and/or 
quence to the underlying substrate. purification of pharmaceutical compounds, chromato- 
use on most polymer substrates having inert hydropho- Petri dishes, membranes for enhancing an evaluation 
bic surfaces. Such polymers are either carbon or silicon 35 rate Of malignant f l o w t h y  vascular conduits for 
based. Representative examples of typical carbon-based microfW~tY Cell culturing, diagnostic membranes for 
polymers include polyolefms such as high and low den- immune response 
sity polyethylene and polypropylene, poly(e- Serological techniques such as enzyme-linked im- 
thyleneterephthalate), polyimides, polystyrene, polytet- munosorbent assay for determining the Pres- 
rafluoroethylene, poly(viny1idene fluoride), and the # ence Of antigens are enhanced by using a membrane 
&e. Examples of silicon+ased polymers in- wherein one surface is made hydrophilic by the method 
polydimethylsiloxane, po~mheny~s~oxane, dime- Of the present invention. SUCCeSSiVe sera liquids used by 
thylsiloxane/methylvinylsiloxane copolymer, cross- the ELI% test Can be easily drawn through the mem- 
linked polysiloxanes obtained by hy&osilylation, con- brane into an absorbent Cotton Or tissue paper using 
densation or free radical crosslifig of siloxane pre- 45 surface energy forces, thus avoiding undesirable wash- 
polymers or organosiloxane polymer mixtures, and the ing steps which would otherwise be necessW- In Such 
like. a manner, waste liquids can be more easily limited and 
Substrates may have most commonly b o w  forms confined. The hydrophobic side of the membrane is 
including textiles, tubes, films, membranes, sheets, preferably used for the test reagent side and the hydro- 
molded forms, as well as composite films, membranes, 50 philic side is set adjacent the absorbent paper to draw 
textiles, and the l i e  with other inert polymeric and away the reagents and other test fluids from the test site. 
non-polymeric materids used for reinforcement. As an The ELISA test can be conducted using the modified 
example, a breathable, hydrophobic polysiloxane mem- membrane in either the "sandwich" method or the indi- 
brane reinforced with poly(tetrafluoroethy1ene) is sold rect method. The methods of the ELISA test are well 
under the tradename SILON by Bio-Med Sciences, Inc. 55 known in the art. 
This membrane is typically used as wound dressings, Cell culturing techniques can be enhanced using pol- 
gas and fluid exchange membranes, etc. ymeric membranes modified by the method of the pres- 
Compatibilized articles made by the method of the ent invention, especially for culturing cells that require 
invention fmd widespread use in biotechnical and bio- anchorage to a hydrophilic surface to grow. Modified 
medical application. By "biotechnical" it is understood 60 membranes having various hydrophilichydrophobic 
to mean application to vitro processes. Examples of in surface patterns can be made by masking the membrane 
vitro processes include manufacturing and purifying before exposure to the atomic oxygen. Such modified 
biocompounds such as lipids, complex carbohydrates, membranes can be used as partitions in cell cultures. As 
proteins and nucleic acids; preparing pharmaceutical one example, the membranes may be masked using a 
chemicals used as drugs, drug intermediates, and the 65 checkerboard stencil, and then modified by atomic oxy- 
l ie ;  and cell culturing processes for drug manufacture, gen treatment to form hydrophilic surface areas sepa- 
preparing organisms having altered genes, prostheses rated by hydrophobic boundaries. In a cell culture, each 
manufacture, and the like. "Biomedical" generally re- hydrophilic area comprises a separate microculture 
0 
II 
II 
CF3CH2-S-Cl. 
0 
group in a 3o 
n e  method of the present invention is suitable for graphic resins, improved cell Culturing membranes and 
and the like* 
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because cell growth is substantially confined to the 
hydrophilic area. Therefore, the hydrophilic “squares” 
typically have an area several times larger than the size 
of the cell to be grown. Cells cultured on the checker- 
board membrane at an average density of about one cell 
per hydrophilic square or less form microcultures 
which can be used to greatly reduce the time and 
amount of materials required, for example, to make 
malignant cell growth evaluations of cells taken from 
tissue biopsies. A percentage of malignant growing cells 
can then be easily determined by observation of the 
whole. 
Typically, tissue biopsy cells are evaluated for can- 
cerous growth by culturing individual cells separately, 
and then observing the growth after a period of time. 
To insure no more than one cell per culture, the cells 
are ordinarily diluted serially using growth media to a 
concentration of about 0.6-0.8 cells per culture area. 
The less culture area required to differentiate between 
the cells, the less time and nutrients that are generally 
necessary for the evaluation. Typically, the area of the 
prior art evaluation cultures is about 0.25 cm2. 
Cell can be cultured in a vessel partitioned by a per- 
meable membrane into compartments. Nutrients and/or 
products made by the culture may diffuse across the 
membrane. For example, a cell culture can be grown in 
a growth medium in a vessel wherein nutrients are self- 
replenished as used. The vessel is partitioned by a modi- 
fied membrane of the present invention into dual com- 
partments. The modified membrane has a hydrophobic 
surface and a hydrophilic surface. In one compartment 
adjacent the membrane hydrophobic surface, cells are 
cultured. The other compartment adjacent the mem- 
brane hydrophilic surface has growth medium. Nutrient 
diffusion from the nutrient compartment replenishes 
nutrients in the cells compartment as they are used. 
Bioreactors partitioned by the modified membranes 
of the present invention as above can polarize the cells 
and thereby enhance production and separation of se- 
12 
shown in the Table. The membrane initially has a hy- 
drophobic surface which after treatment acquires hy- 
drophilic hydroxyl functionality as follows: 
5 
before after 
Surface 
CH3 CH3 OH OH 
I I I I 
I I I I 
lo -fSi-O-si-f;; + I@+ -fSi-O-Si-t;; + 6Hz0 + 4c02 
OH OH CH3 CH3 
Sub- 
Surface 
l5 CH3 CH3 CH3 CH3 
*Si-0-Si-t;; I I *Si-0-Si.);; I I 
I I I I 
CH3 CH3 CH3 CH3 
20 
pressure (pa) 21 
temp (“K) 298 
gas mixture 10% 0 2  in Ar 
C(z) (AO/cm’) 4 x 1014 25 
Example 2 
The membrane of Example 1 is reacted with a silane 
coupling agent to graft glycidyl functionality to the 
substrate surface. The grafting reaction proceeds as 
follows: 
30 
35 
R 
I o  
-Si-0-Si-R 
I 
-Si-OH 
I I o  
I I + RSi(OR)3 R 
I n  0 
R 
-Si-0-Si-R 
f creted biological products. Depending on the cells in- 40 volved, polarization can occur in due course as cells adhere to a hydrophilic surface on the membrane and- 
/or in response to a concentration gradient set up by a 
case, the cells define a basal cell wall adhered against 45 
the membrane partition and an opposite apical cell wall. 
The membrane of such bioreactors hydrophobic “Iface adjacent a Preferably has a 3-Glycidylpropyltrismethoxys~ane obtainable from 
ment except for an isolated hydrophilic area, such as, 
for example, a line or a strip for cell attachment. The 50 water to make a wt. % 
other surface of the membrane adjacent a nutrient com- solution ofthe glYcidY1 compound. The PH ofthe Soh- 
partment can be hydrophobic or hydrophilic. Nutrients tion is adjusted to between about 4.5-5.5 with sodium 
from the nutrient compartment diffuse through the acetate. The membrane from Example 1 is placed into 
membrane by concentration gradient to replenish nutri- the solution for 1-2 minutes then removed and rinsed 
ents used by the cells. Desired products made by the 55 with ethanol. After drying for 5-10 at c. or for cells secrete through the basal cell wall and diffuse 
though the membrane partition into the nutrient 2.5 hrs in a desiccator, the membrane is used for further 
partment. In such manner, desired cell products can be reaction- 
recovered without lysing the cells. 
following examples: 
-Si-OH 
I n  
nutrient factor diffusing across the membrane. In either R 
wherein R and R are as previously defined. 
culture cornpart- Huls-Petrarch (item G6772) is dissolved in an ethanol/- 
(95 wt. % 
Examples 3-4 
Compatibilizing phosphorylcholine functionality is 
grafted to the surface of the membranes of Example 2 to 
mimic a cell membrane. 
The membrane Of 
water solution of ethyleneglycophosphorylcholine for 
16 hours. The pH of the reaction medium is 4.5 to 6. The 
reaction is as follows: 
The method of the invention is illustrated by the 60 
Example 1 
A polytetrafluoroethylene reinforced silicone mem- 
brane sold under the tradename SILON by Bio-Med 65 
Sciences, Inc. of Bethlehem, Pa. is uniformly treated 
with atomic oxygen in an atomic oxygen reactor having 
a specimen holding sidearm. Operating conditions are 
is stirred in a 400 
13 
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-continued 
R Tresyl 
-Si-OSi(CH2)3O-CHCHzTresyl 
I o  I 
I o  
R 
I 0 .  /O\ 
-?-O-Si-(CH2)3-O-CH - CHI 
+ 
R' 
P o  /O\ 
-Si-O-Si-(CH2)3-O-CH - CH2 
I n  0 
R 
5 
10 
I 
R + GRGD- 
R Tresyl 
P o  I 
-Si-OSi(CH2)3O-CHCHzTresyl 
I n  0 
R 
0 R' NH(GRGD) 
I1 I o  I 
HO-CH~CH~OPOCHZCH~~(CH~)~+ -Si-OSi(CH2)3O-CHCH2NH(GRGD) 
I 
15 0- 
NH(GRGD) R 
0 1 R OH 0 I o  I I1 
I 
-Si-OSi(CH2)30-CHCHzNH(GRGD) -S~-OS~(CH~)~O-CHCH~O-CH~CHZOPOCH~CH~N(CH~)~ + I n  0 
R 
20 
0- 
OH 0 The glycidyl functionalized membrane from Example I I1 2 is initially hydrolyzed in dilute acid (PH of about 2) by 
stirring for 2 hrs at 25" C. The hydrolyzed glycidyl 
groups are reacted with tresyl chloride in dry ether. 
25 The membrane is contacted with a 1.0 wt. % ether 
solution of the tresyl chloride at 25" C. for 15 min then 
1 is coupled to the ethYleneglYcoPhosPhorYlChOline rinsed with 0.2M bicarbonate buffer solution having a 
Using dichlorodimethylsilane. First, the PhosPhorYlcho- pH of 10. In fresh buffer solution, the tresyl chloride 
line is reacted at with the dichlorodimethylsilane in fwctionalized membrane is reacted with the peptide for 
anhydrous tetrahydrofuran (THF) using excess silane 30 20 hrs at 25" C. The peptide sequence is attached at the 
for 1 hr at 25" C. to prepare a chlorosilane/phosphoryl- terminal amino functionality on the glycine unit. 
choline intermediate. Next, the intermediate product is 
recovered by evaporating the solvent and excess unre- 
acted silane. The intermediate is then reacted with the 35 
Example 1 membrane in dry THF also at 25" c. for 16 
hrs with stirring to complete the graft reaction. 
-Si-OSi(CH~)~O-CHCH~O-CH~CH~Op~H~CH~N(CH~)~ 1 + 
0- I n  0 R' 
As an alternative the membrane Of 
Example 7 
In the following example, a vascular prosthesis is 
initially made according to Example 6 except that the 
SILON substrate has the form of a small bore tube. In 
the atomic oxygen treating first step, the outside surface 
of the tube is made hydrophilic to of the wall thick- 
ness. Arterial endothelial cells are cultured on the 
which is suitable for implant into a patient suffering 
advanced arteriosclerosis. 
Example 8 
A vascular prosthesis is made 
Example 5 
this reaction, a compatibilizing polymer segment is 
grafted to the surface glycidyl functionality ofthe mem- treated surface to a compatibilized 
brane of Example 2. 
A poly(viny1 alcohol) segment is grafted to the mem- 
brane by reaction in water at 25" C. for 16 hrs with 
stirring. Reaction p~ is 4.5-5.5. Further details regard- 45 
ing the Optimized surface loading (# of grafts) and mo- 
lecular weight distribution of the polymer with respect 
to a particular application may be found in the article by 
Y. Ikada mentioned previously. 
to Example 
porous form made by a repl-nefom casting proce- 
7 except that the tubular silicone substrate has a micro- 
dure described in Stimpson above which is hereby in- 
50 corporated herein by reference. 
Example 6 Example 9 
A tetrapeptide glycine-arginine-glycine-asparagine In the following example, an ELISA serological im- 
(GRGD) containing the cell adhesion sequence argi- mune diagnostic technique is conducted using a 2.5 cm 
nine-glycine-asparagine (RGD) is grafted to the surface 55 diameter, 100 pm thick SILON membrane treated with 
of the membrane of Example 2. Tresyl chloride is used a uniform dose of atomic oxygen according to the pro- 
as a second coupling agent as follows: cedure of Example 1 so that one side is hydrophilic and 
the other remains hydrophobic. The direct sandwich 
method is used. 
OH The membrane is placed hydrophilic side down on a 
glass petri dish and a drop of antiserum containing a 
polyclonal anti-IgG antibody obtained as a 1 pl concen- 
tration from Sigma Corp. of St. Louis is placed on the 
R OH II membrane and allowed to dry. Next, absorbent tissue 
65 paper is placed under the membrane hydrophilic side 
and a drop of a test serum containing complementary 
antigens is placed over the antibodies. The complemen- 
tary antigens adhere to the anti-IgG antibodies and 
60 
R' 
I o  I 
-Si-OSi(CH2)3O-CHCHzOH 
0 
+ CF3CH2-S-CI+ II 
0 I 
-Si-OSi(CHz)3O-CHCHzOH 
I n  0 
R 
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excess fluid is absorbed through the membrane into the as a matter of course upon adherence to the hydrophilic 
tissue paper. Using fresh absorbent tissue paper in a “line” so that a distinct basal cell wall is formed adhered 
fresh petri dish, a second drop of antiserum containing to the membrane as well as an opposite apical cell wall. 
1 part complementary anti-IgG antibodies per 2000 In the course of the culture, nutrients diffuse across the 
parts water is placed over the antibody-antigen combi- 5 membrane to replenish the cell growth media and the 
nation except that these second antibodies are conju- cell growth differentiation factors produced by the 
gated to an enzyme alkaline phosphatase. Adherence of cultured cells are secreted by the basal cell wall and 
these additional antibodies to the antigens mark the migrate through the membrane partition. After 30 days, 
antigens with the enzyme. Excess liquids diffuse the confluency in the opposite compartment is greater 
through the membrane and are absorbed by the paper. 10 than 10 picomoles of the growth differentiation factors. 
Using fresh tissue paper in a fresh petri dish, a drop of 
phosphatase-react&e- chromagen is .placed over -the 
membrane “sandwich.” Since phosphatase marked anti- 
gens are present, a black chromagen-phosphatase prod- 
uct forms. Excess fluid is drawn through the membrane 
and is absorbed leaving the black colored “sandwich.” 
The modified membrane allows waste liquids to be 
absorbed away from the test area for easy disposal. 
Example 10 
In the following example, time required to differenti- 
ate the growth rate of normal cells from malignant cells 
in a tissue biopsy is determined using a hydrophilic 
modified membrane of the present invention. The mem- 
brane has a surface wherein a plurality of hydrophilic 
surface areas are separated by a hydrophobic boundary 
so that each hydrophilic area is an isolated microcul- 
ture. 
The test is undertaken using a 2.5 cm diameter, 100 
pm thick SILON membrane exposed to a uniform dos- 
age of atomic oxygen according to Example 1, except 
that the membrane is masked during the atomic oxygen 
treatment. The mask gives the membrane a surface 
feature wherein hydrophilic areas of about 200 pm2 are 
bounded by similarly sued hydrophobic regions in a 
checkerboard manner. The treated membrane is placed 
in a petri dish. The biopsy cells are serially diluted with 
cell culture media so that there will be about 0.7 cells 
per 200 pm2 membrane area in the culture and the 
growth solution containing the cells is then added to the 
dish. 
After one week, observation of the growth area 
under a microscope indicates that malignancy growth 
evaluation may be made in one tenth the time ordinarily 
required using 0.25 cm2 size cultures in the prior art 
methods. Likewise, only one tenth the amount of cul- 
ture materials is required. 
Example 11 
In the following example, a modified membrane of 
the present invention is used to separate a cultured 
product comprising cell growth differentiation factors 
from the cells without lysis. 
Normal human primary cells taken from a surgical 
section are cultured in a petri dish having a modified 
membrane partition. COz incubation conditions are used 
to produce cell growth differentiation factors wherein 
the cell are polarized by a 2.5 cm2 SILON diffiusion 
membrane which is 100 pm thick. The membrane is 
Example 12 
In the following example, a modified membrane can 
be used to allow continual replenishment of nutrients to 
15 a cell culture. A petri dish culture is partitioned by 
modified membrane as described in Example 11 except 
that the SILON membrane is treated with atomic oxy- 
gen so that one side is hydrophilic and the other remains 
hydrophobic. The hydrophilic side forms the nutrient 
20 compartment and the cells are cultured in growth media 
adjacent the hydrophobic side. As nutrients in the 
growth medium are used by the cells, replenishing nu- 
trients diffuse from the nutrient compartment to the 
cells compartment through the membrane. 
The foregoing description of the invention is illustra- 
tive and explanatory thereof. Various changes in the 
materials, apparatus, and particular parts employed will 
occur to those skilled in the art. It is intended that all 
such variations within the scope and spirit of the ap- 
25 
30 pended claims be embraced thereby. 
What is claimed is: 
1. An organic polymer membrane having first and 
second opposing surfaces, wherein said first surface is 
hydrophilic and has an adjacent absorbent layer and 
35 said second surface is hydrophobic and contains ad- 
hered antibodies, said hydrophilic surface is prepared 
by a method comprising: 
exposing a hydrophobic exterior surface of said mem- 
brane to a dosage of atomic oxygen or hydroxyl 
radicals at a temperature below about 40” C., said 
dosage being sufficient to form said hydrophilic 
surface having a uniform surface layer of hydro- 
philic functional hydroxyl groups, wherein said 
dosage is generated by a flowing afterglow micro- 
wave discharge and said surface is outside of a 
plasma produced by said discharge, wherein said 
surface exposed to said dosage has a depth of from 
about 50 to about 5000 angstroms and said dosage 
over said surface is within about 10 percent of an 
2. An organic polymer membrane having a surface 
comprised of a plurality of hydrophilic regions bounded 
by adjacent hydrophobic regions, said hydrophilic re- 
gions containing adhered cells at a maximum density of 
55 one cell per each hydrophilic region and said hydropho- 
bic regions are substantially free of adhered cells, said 
hydrophilic regions having a uniform surface layer of 
hydrophilic functional hydroxyl groups created by ex- 
posing an exterior hydrophobic surface of said mem- 
40 
45 
50 average dosage. 
treated on both sides with a uniform dose of atomic 60 brane-at a temperature beiow about 40“ C. to a dosage 
oxygen according to the procedure of Example 1. One of atomic oxygen or hydroxyl radicals, said dosage 
membrane side is hydrophilic and the other remains being generated by a flowing afterglow microwave 
hydrophobic except for a horizontal hydrophilic line discharge and said surface being outside of a plasma 
made by masking the treated surface. In the culture, the produced by said discharge, wherein said exterior sur- 
cells are added to the partition side having the linear 65 face exposed to said atomic oxygen has a depth of from 
hydrophilic area bounded by the hydrophobic area and about 50 to about 5000 angstroms and said dosage over 
growth media is added to the other side of the mem- said surface is within about 10 percent of an average 
brane having the hydrophilic surface. The cells polarize dosage. 
5,369,012 
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3. The membrane of claim 2 wherein said hydrophilic cell per each hydrophilic region and said hydro- 
regions are grafted with a compatibilizing compound phobic regions are substantially free of adhered 
selected from the group consisting of phosphorylcho- cells; 
lines, peptides, lipids, proteins, nucleic acids, poly(ethy- (b) growing said cells on said membrane; and 
lene oxide), poly(viny1 alcohol) and acyl terminated 5 (c) obtaining a count of malignant cells growing on 
upper alkyl radicals. said membrane. 
4. The membrane of claim 3 wherein said compound 9. A cell culturing method using a permeable organic 
is selected from the group consisting of one or more polymer membrane having first and second opposing 
phosphorylcholines, peptides, lipids, proteins, and nu- surfaces, said first surface comprising a hydrophilic 
cleic acids. region bounded by a hydrophobic region, said hydro- 
5. The membrane of claim 3, wherein said compatibil- lo philic region having a uniform surface layer of hydro- 
king compound is selected from the group consisting of philic functional hydroxyl groups created by exposing 
poly(viny1 alcohol) and poly(ethy1ene oxide). an exterior hydrophobic surface of said membrane at a 
6- The membrane of Claim 2 in the form of a tube. temperature below about 40" C. to a dosage of atomic 
7- An assay method Using a Permable Organic Poly- oxygen or hydroxyl radicals, said dosage being gener- 
mer n m d ~ a n e  having a hydrophilic surfax fOrmed 15 ated by a flowing afterglow microwave discharge and 
Opposite a hydrophobic surface) said hydrophilic Sur- said surface being outside of a plasma produced by said 
face having a uniform surface layer OfhYdrOPhilic func- discharge, wherein said exterior surface exposed to said 
tional hydroxyl groups crcited by exposing an exterior atomic oxygen has a depth of from about 50 to about 
hydrophobic surface of said membrane at a temperature 5000 angstroms and said dosage over said surface is 
about 40" c- to a dosage Of atomic Oxygen Or 20 within about 10 percent of an average dosage, second 
hydroxyl radicals, said dosage being generated by a said cell culture method comprising the steps of: 
flowing afterglow microwave discharge and said sur- and product compartments 
face being outside of a plasma produced by said dis- on opposite sides of said membrane, wherein said 
first membrane surface is adjacent to said cell cul- charge, wherein said surface exposed to said atomic 
turing compartment and said second membrane oxygen has a depth of from about 50 to about 5000 
surface is adjacent to said product compartment, angstroms and said dosage over said surface is within 25 
said cell culturing compartment comprising cells in about 10 percent of an average dosage, said assay com- 
a growth medium, said cells having a gene for prising the steps of: 
expression of a desired product; (a) adhering known antibodies to said hydrophobic 
(b) inducing said cells to adhere to said hydrophilic surface; 
region of said first surface of said membrane, (b) placing said hydrophilic surface in contact with an 30 adjacent absorbent material; wherein said cells polarize with a basal cell wall (c) covering said antibodies with a test solution, adjacent said first surface; and wherein antigens specific to said antibodies adhere 
thereto to an antibody-antigen complex and (c) inducing migration of said nutrient from said nu- 
surface and are absorbed by said absorbent mate- maintaining nutrient in said cell culturing compart- 
rial; ment, wherein said cells absorb said nutrient and in 
(d) covering said hydrophobic surface with a solution response thereto secrete a product preferentially 
of said antibodies conjugated to an indicating en- through said basal cell wall and said membrane into 
zyme, wherein said conjugated antibodies and said said product compartment. 
antigen-antibody complex form an antibody-anti- 40 10. A Cell Culturing method using a permeable or- 
gen-antibody/enzyme complex and excess fluid is ganic Polymer membrane, said membrane having first 
absorbed by said absorbent materia and and second opposing surfaces, said first surface com- 
(e) developing said antibody-antigen-antibody/en- PriSing a hydrophilic surface and said second surface 
zyme complex with a solution of developing corn- comprising a hydrophobic surface, said hydrophilic 
pound reactive with said enzyme to indicate pres- 45 Surface having a Uniform surface layer Of hydrophilic 
ence of said antibody-antigen-antibody/enzyme functional hydroxyl groups created by exposing an 
complex as a positive result or an absence of said exterior hydrophobic surface of said membrane at a 
complexes as a negative result, wherein excess temperature below about 40" C. to a dosage of atomic 
developing solution is absorbed by said absorbent Oxygen Or hydroxyl radicals, said dosage being gener- 
material. 50 ated by a flowing afterglow microwave discharge and 
8. A cell culturing method using a permeable organic said surface being outside of a plasma produced by said 
polymer membrane having a hydrophilic surface corn- discharge, wherein said exterior surface exposed to said 
prising a plurality of hydrophilic regions bounded by atomic oxygen has a depth of from about 50 to about 
adjacent hydrophobic regions, said hydrophilic regions 5000 angstroms and said dosage Over said surface is 
having a uniform surface layer of hydrophilic functional 55 within about 10 Percent of an average dosage, said cell 
hydroxyl groups created by exposing an exterior hydro- culture method Comprising the steps Of: 
phobic surface of said membrane at a temperature (a) forming a nutrient compartment and a Cells com- 
below about 40" C. to a dosage of atomic oxygen or partment on opposite sides of said membrane, 
hydroxyl radicals, said dosage being generated by a wherein said first surface is adjacent said nutrient 
flowing afterglow microwave discharge and said sur- compartment and said second surface is adjacent to 
face being outside of a plasma produced by said dis- a said cells compartment, said nutrient compartment 
charge, wherein said exterior surface exposed to said comprising a solution of nutrient and said cells 
atomic oxygen has a depth of from about 50 to about compartment comprising cells in a growth me- 
5000 angstroms and said dosage over said surface is dium; and 
within about 10 percent of an average dosage, said cell (b) inducing migration of said nutrient from said nu- 
culturing method comprising the steps of: trient compartment to said cells compartment by 
(a) distributing a group of cells on said membrane in maintaining a higher concentration of said nutrient 
a growth medium, wherein said cells adhere to said in said nutrient compartment. 
(a) forming cell 
non-a&ered antigens migrate to said hydrophilic 35 trient compartment to said compartment by 
65 
hydrophilic regions at a maximum density of one * * * * *  
